Back to search

Article

Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy

2024-12-31

Abstract excerpt

Acquired resistance to targeted non-intensive therapies is common in myeloid malignancies. Yet, key questions remain as to how rapidly resistant clones are selected by treatment and in which hematopoietic cell compartments clonal selection occurs. To address this gap, we studied clonal responses to ivosidenib + venetoclax +/- azacitidine combination therapy in 8 patients with IDH1-mutant myeloid malignancy. Whilst...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8ef2c93-c7ef-5315-a832-ccf1e0045dfe
DOI
10.1101/2024.12.30.630700
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapyDOI 10.1101/2024.12.30.630700
Select a neighboring publication to make it the new centre.